UNC50 prompts G1/S transition and proliferation in HCC by regulation of epidermal growth factor receptor trafficking

PLoS ONE

Volumn 10, Issue 3, 2015, Pages

  Fang, Zhou ^a   Zhou, Linuo ^b   Jiang, Songmin ^a   Cao, Lihuan ^a   Yu, Long ^a,c  

^a FUDAN UNIVERSITY   (China)

^b FUDAN UNIVERSITY   (China)

^c FUDAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CELL PROTEIN; CYCLIN D1; EPIDERMAL GROWTH FACTOR; EPIDERMAL GROWTH FACTOR RECEPTOR; GASTRIN; MATRILYSIN; MESSENGER RNA; MUCIN 1; PROTEIN UNC50; UNCLASSIFIED DRUG; EGFR PROTEIN, HUMAN; LIGAND; MEMBRANE PROTEIN; RNA BINDING PROTEIN; UNC50 PROTEIN, HUMAN;

AKR1B10 GENE; ARTICLE; CANCER GROWTH; CELL PROLIFERATION; CONTROLLED STUDY; CYCLIN D1 GENE; EPIDERMAL GROWTH FACTOR GENE; FLOW CYTOMETRY; G1 PHASE CELL CYCLE CHECKPOINT; GASTRIN GENE; GENE; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MATRIX METALLOPROTEINASE 7 GENE; MICROARRAY ANALYSIS; MUCIN 1 GENE; NORTHERN BLOTTING; NUCLEOTIDE SEQUENCE; PROTEIN FUNCTION; PROTEIN TRANSPORT; REAL TIME POLYMERASE CHAIN REACTION; UNC50 GENE; WESTERN BLOTTING; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; DEFICIENCY; DISEASE COURSE; GENE SILENCING; GENETICS; LIVER TUMOR; METABOLISM; PATHOLOGY; TUMOR CELL LINE; UPREGULATION;

CAENORHABDITIS ELEGANS; EUKARYOTA;

CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; CELL PROLIFERATION; DISEASE PROGRESSION; G1 PHASE; GENE KNOCKDOWN TECHNIQUES; HUMANS; LIGANDS; LIVER NEOPLASMS; MEMBRANE PROTEINS; PROTEIN TRANSPORT; RECEPTOR, EPIDERMAL GROWTH FACTOR; RNA-BINDING PROTEINS; S PHASE; UP-REGULATION;

EID: 84928911668     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0119338     Document Type: Article

References (26)

1. El-Serag HB, Rudolph KL. Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology 2007;132:2557-2576. PMID: 17570226
2. Patil MA, Chua MS, Pan KH, Lin R, Lih CJ, Cheung ST, et al. An integrated data analysis approach to characterize genes highly expressed in hepatocellular carcinoma. Oncogene 2005;24:3737-3747. PMID: 15735714
3. Hanahan D, Weinberg RA. The hallmarks of cancer. Cell 2000;100:57-70. PMID: 10647931
4. Ciardiello F, Tortora G. A novel approach in the treatment of cancer: targeting the epidermal growth factor receptor. Clinical cancer research: an official journal of the American Association for Cancer Research 2001;7:2958-2970.
5. Mendelsohn J, Baselga J. Status of epidermal growth factor receptor antagonists in the biology and treatment of cancer. Journal of clinical oncology: official journal of the American Society of Clinical Oncology 2003;21:2787-2799.
6. Desbois-Mouthon C, Cacheux W, Blivet-Van Eggelpoel MJ, Barbu V, Fartoux L, Poupon R, et al. Impact of IGF-1R/EGFR cross-talks on hepatoma cell sensitivity to gefitinib. International journal of cancer Journal international du cancer 2006;119:2557-2566. PMID: 16988945
7. Philip PA, Mahoney MR, Allmer C, Thomas J, Pitot HC, Kim G, et al. Phase II study of Erlotinib (OSI-774) in patients with advanced hepatocellular cancer. Journal of clinical oncology: official journal of the American Society of Clinical Oncology 2005;23:6657-6663.
8. Thomas MB, Chadha R, Glover K, Wang X, Morris J, Brown T, et al. Phase 2 study of erlotinib in patients with unresectable hepatocellular carcinoma. Cancer 2007;110:1059-1067. PMID: 17623837
9. Schiffer E, Housset C, Cacheux W, Wendum D, Desbois-Mouthon C, Rey C, et al. Gefitinib, an EGFR inhibitor, prevents hepatocellular carcinoma development in the rat liver with cirrhosis. Hepatology (Baltimore, Md) 2005;41:307-314. PMID: 15660382
10. Fuchs BC, Hoshida Y, Fujii T, Wei L, Yamada S, Lauwers GY, et al. Epidermal growth factor receptor inhibition attenuates liver fibrosis and development of hepatocellular carcinoma. Hepatology (Baltimore, Md) 2014;59:1577-1590. doi: 10.1002/hep. 26898 PMID: 24677197
11. Chantalat S, Courbeyrette R, Senic-Matuglia F, Jackson CL, Goud B, Peyroche A. A novel Golgi membrane protein is a partner of the ARF exchange factors Gea1p and Gea2p. Molecular biology of the cell 2003;14:2357-2371. PMID: 12808035
12. Brenner S. The genetics of Caenorhabditis elegans. Genetics 1974;77:71-94. PMID: 4366476
13. Lewis JA, Wu CH, Berg H, Levine JH. The genetics of levamisole resistance in the nematode Caenorhabditis elegans. Genetics 1980;95:905-928. PMID: 7203008
14. Eimer S, Gottschalk A, Hengartner M, Horvitz HR, Richmond J, Schafer WR, et al. Regulation of nicotinic receptor trafficking by the transmembrane Golgi protein UNC-50. The EMBO journal 2007;26:4313-4323. PMID: 17853888
15. Cury PR, De Araujo VC, Canavez F, Furuse C, Leite KR, De Araujo NS. The effect of epidermal growth factor on matrix metalloproteinases and tissue inhibitors of metalloproteinase gene expression in cultured human gingival fibroblasts. Archives of oral biology 2007;52:585-590. PMID: 17181997
16. Liu Z, Yan R, Al-Salman A, Shen Y, Bu Y, Ma J, et al. Epidermal growth factor induces tumour marker AKR1B10 expression through activator protein-1 signalling in hepatocellular carcinoma cells. The Biochemical journal 2012;442:273-282. doi: 10.1042/BJ20111322 PMID: 22329800
17. Neeraja D, Engel BJ, Carson DD. Activated EGFR stimulates MUC1 expression in human uterine and pancreatic cancer cell lines. Journal of cellular biochemistry 2013;114:2314-2322. doi: 10.1002/jcb. 24580 PMID: 23686469
18. Ford MG, Valle JD, Soroka CJ, Merchant JL. EGF receptor activation stimulates endogenous gastrin gene expression in canine G cells and human gastric cell cultures. The Journal of clinical investigation 1997;99:2762-2771. PMID: 9169507
19. Kim HJ, Choi YS, Jeong MJ, Kim BO, Lim SH, Kim Do K, et al. Expression of UNCL during development of periodontal tissue and response of periodontal ligament fibroblasts to mechanical stress in vivo and in vitro. Cell and tissue research 2007;327:25-31. PMID: 17004066
20. Wang Y, Yang H, Xu H, Lu X, Sang X, Zhong S, et al. Golgi protein 73, not Glypican-3, may be a tumor marker complementary to alpha-Fetoprotein for hepatocellular carcinoma diagnosis. Journal of gastroenterology and hepatology 2014;29:597-602. doi: 10.1111/jgh.12461 PMID: 24236824
21. Yang Y, Luo Y, Li X, Yi Y. Differential expression analysis of Golgi apparatus proteomes in hepatocellular carcinomas and the surrounding liver tissues. Hepatology research: the official journal of the Japan Society of Hepatology 2014;44:542-550. doi: 10.1111/hepr.12151 PMID: 23621634
22. Costanzo M, Baryshnikova A, Bellay J, Kim Y, Spear ED, Sevier CS, et al. The genetic landscape of a cell. Science (New York, NY) 2010;327:425-431. doi: 10.1126/science.1180823 PMID: 20093466
23. Surma MA, Klose C, Peng D, Shales M, Mrejen C, Stefanko A, et al. A lipid E-MAP identifies Ubx2 as a critical regulator of lipid saturation and lipid bilayer stress. Molecular cell 2013;51:519-530. doi: 10. 1016/j.molcel.2013.06.014 PMID: 23891562
24. Herbst JJ, Opresko LK, Walsh BJ, Lauffenburger DA, Wiley HS. Regulation of postendocytic trafficking of the epidermal growth factor receptor through endosomal retention. The Journal of biological chemistry 1994;269:12865-12873. PMID: 8175702
25. Stoscheck CM, Carpenter G. Characterization of the metabolic turnover of epidermal growth factor receptor protein in A-431 cells. Journal of cellular physiology 1984;120:296-302. PMID: 6086681
26. Fitzgerald J, Kennedy D, Viseshakul N, Cohen BN, Mattick J, Bateman JF, et al. UNCL, the mammalian homologue of UNC-50, is an inner nuclear membrane RNA-binding protein. Brain research 2000;877:110-123. PMID: 10980252